Systemic Risk Score Evaluation in Ischemic Stroke Patients (SCALA)
Christian Weimar(Institut für Medizinische Informatik, Biometrie und Epidemiologie), Karlheinz Theobald(Sanofi (Germany)), Harald Darius(Vivantes Klinikum), I.-H. Kim(Sanofi (France)), Michael Goertler(German Center for Neurodegenerative Diseases), E. Bernd Ringelstein(University of Münster), Darius G. Nabavi(Vivantes Klinikum), Joachim Röther(Asklepios Klinik Altona), HC Diener(University of Duisburg-Essen)
Cited by 44
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
|European Heart Journal|2022|1.1k
High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study
|Atherosclerosis|2003|824
Action Plan for Stroke in Europe 2018–2030
|European Stroke Journal|2018|616